NCT07186127View on ClinicalTrials.gov

Methotrexate Treatment in Cases of Ectopic Pregnancy With Relative Contraindications

RecruitingOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

May 1, 2026

Conditions
Ectopic Pregnancy
Interventions
DRUG

Drug: Methotrexate (MTX) Patients received methotrexate treatment according to institutional protocols. Dosage and administration routes were recorded retrospectively. For patients who did not respond

MTX medical treatment Laparoscopic salpingectomy Laparoscopic salpingostomy

Trial Locations (1)

34200

RECRUITING

University of Health Sciences, Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Bagcilar Training and Research Hospital

OTHER_GOV